Dr. Martens (LON:DOCS) Shares Down 5.1% - Here's What Happened

Key Points

• Shares fell 5.1% to GBX 62.65 (intraday low GBX 61.95) on Monday with volume of 10.53 million shares, about 151% above the average session volume.
• Analyst coverage is split (two Buy, two Hold) with an average rating of “Moderate Buy”
• The company has a market cap of £605.6m and a P/E of 36.85, is trading below its 50‑day (GBX 71.11) and 200‑day (GBX 80.94) moving averages, and shows a high debt‑to‑equity ratio (120.66).

Dr. Martens plc (LON:DOCS - Get Free Report) traded down 5.1% on Monday . The company traded as low as GBX 61.95 and last traded at GBX 62.65. 10,529,084 shares were traded during trading, an increase of 151% from the average session volume of 4,198,827 shares. The stock had previously closed at GBX 66.

Analyst Ratings Changes

DOCS has been the subject of a number of research reports. Royal Bank Of Canada reiterated a "sector perform" rating on shares of Dr. Martens in a report on Tuesday, February 3rd. Peel Hunt reissued a "buy" rating on shares of Dr. Martens in a report on Thursday, November 20th. Finally, Berenberg Bank reaffirmed a "buy" rating on shares of Dr. Martens in a research note on Tuesday, January 27th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of GBX 6,000.

Dr. Martens Stock Down 5.1%

The stock has a market capitalization of £605.56 million, a P/E ratio of 36.85, a PEG ratio of 6.40 and a beta of 0.20. The stock has a 50 day moving average price of GBX 71.11 and a 200-day moving average price of GBX 80.94. The company has a debt-to-equity ratio of 120.66, a current ratio of 2.18 and a quick ratio of 1.13.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over 60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the 1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and accessories. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.